Ontology type: schema:ScholarlyArticle Open Access: True
2013-09-04
AUTHORSRachel L Atkinson, Wei T Yang, Daniel G Rosen, Melissa D Landis, Helen Wong, Michael T Lewis, Chad J Creighton, Krystal R Sexton, Sue G Hilsenbeck, Aysegul A Sahin, Abenaa M Brewster, Wendy A Woodward, Jenny C Chang
ABSTRACTIntroductionWe hypothesized that cells present in normal tissue that bear cancer stem cell markers may represent a cancer cell of origin or a microenvironment primed for tumor development, and that their presence may correlate with the clinically defined subtypes of breast cancer that show increased tumorigenicity and stem cell features.MethodsNormal tissues sampled at least 5 cm from primary tumors (normal adjacent tissue) were obtained from 61 chemotherapy-naive patients with breast cancer treated with mastectomy. Samples were stained simultaneously with immunofluorescence for CD44/CD49f/CD133/2 stem cell markers. We assessed the association between CD44+CD49f+CD133/2+ staining in normal adjacent tissue and breast cancer receptor subtype (defined by the expression of the estrogen (ER), progesterone (PR), or human epidermal growth factor-2 (Her2) receptors). We also examined the correlation between CD44+CD49f+CD133/2+ immunofluorescence and each of two previously published gene signatures, one derived from stem-cell enriched tissue and one from BRCA mutated tissue expected to have defective DNA repair.ResultsPatients with triple negative breast cancer (ER–/PR–/HER2–) expressed CD44+CD49f+CD133/2+ in 9 of 9 normal adjacent tissue samples compared with 7 of 52 ER+ and/or Her2+ tumors (P < 0.001). Further, expression of CD44+CD49f+CD133/2+ by normal adjacent tissue correlated positively with a stem cell-derived tumorigenic signature (P <0.001) and inversely with a defective DNA-repair signature (P <0.001).ConclusionNormal cells bearing cancer stem cell markers are associated with the triple negative receptor subtype of breast cancer. This study suggests stem cell staining and gene expression signatures from normal breast tissues represent novel tissue-based risk biomarkers for triple negative breast cancer. Validation of these results in additional studies of normal tissue from cancer-free women could lay the foundation for future targeted triple negative breast cancer prevention strategies. More... »
PAGESr77
http://scigraph.springernature.com/pub.10.1186/bcr3471
DOIhttp://dx.doi.org/10.1186/bcr3471
DIMENSIONShttps://app.dimensions.ai/details/publication/pub.1026013878
PUBMEDhttps://www.ncbi.nlm.nih.gov/pubmed/24008095
JSON-LD is the canonical representation for SciGraph data.
TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT
[
{
"@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json",
"about": [
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/11",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Medical and Health Sciences",
"type": "DefinedTerm"
},
{
"id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/1112",
"inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/",
"name": "Oncology and Carcinogenesis",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "AC133 Antigen",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antigens, CD",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Antigens, Surface",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Biomarkers",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Cell Transformation, Neoplastic",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "DNA Repair",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Epidemiologic Factors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Female",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Gene Expression Profiling",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Glycoproteins",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Humans",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Hyaluronan Receptors",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Integrin alpha6",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Mammary Glands, Human",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Neoplastic Stem Cells",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Peptides",
"type": "DefinedTerm"
},
{
"inDefinedTermSet": "https://www.nlm.nih.gov/mesh/",
"name": "Triple Negative Breast Neoplasms",
"type": "DefinedTerm"
}
],
"author": [
{
"affiliation": {
"alternateName": "Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Atkinson",
"givenName": "Rachel L",
"id": "sg:person.01307651371.05",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01307651371.05"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Diagnostic Imaging, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Yang",
"givenName": "Wei T",
"id": "sg:person.014215500134.53",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014215500134.53"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Pathology, Baylor College of Medicine, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Pathology, Baylor College of Medicine, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Rosen",
"givenName": "Daniel G",
"id": "sg:person.01350076527.15",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01350076527.15"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.63368.38",
"name": [
"The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Landis",
"givenName": "Melissa D",
"id": "sg:person.01116754310.56",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01116754310.56"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.63368.38",
"name": [
"The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Wong",
"givenName": "Helen",
"id": "sg:person.01173170315.59",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01173170315.59"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA"
],
"type": "Organization"
},
"familyName": "Lewis",
"givenName": "Michael T",
"id": "sg:person.01220660505.72",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01220660505.72"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA"
],
"type": "Organization"
},
"familyName": "Creighton",
"givenName": "Chad J",
"id": "sg:person.0667706307.09",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0667706307.09"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA"
],
"type": "Organization"
},
"familyName": "Sexton",
"givenName": "Krystal R",
"id": "sg:person.0702266064.11",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.0702266064.11"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA",
"id": "http://www.grid.ac/institutes/grid.39382.33",
"name": [
"Lester & Sue Smith Breast Center, Baylor College of Medicine, Houston, USA"
],
"type": "Organization"
},
"familyName": "Hilsenbeck",
"givenName": "Sue G",
"id": "sg:person.07660101167.52",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.07660101167.52"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Pathology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Sahin",
"givenName": "Aysegul A",
"id": "sg:person.015041554177.45",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.015041554177.45"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Brewster",
"givenName": "Abenaa M",
"id": "sg:person.016133406417.66",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.016133406417.66"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.240145.6",
"name": [
"Departments of Radiation Oncology, The University of Texas MD Anderson Cancer Center, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Woodward",
"givenName": "Wendy A",
"id": "sg:person.01340635437.54",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.01340635437.54"
],
"type": "Person"
},
{
"affiliation": {
"alternateName": "The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA",
"id": "http://www.grid.ac/institutes/grid.63368.38",
"name": [
"The Methodist Hospital Research Institute, 6445 Main Street, 21st Floor, 77030, Houston, TX, USA"
],
"type": "Organization"
},
"familyName": "Chang",
"givenName": "Jenny C",
"id": "sg:person.014767761117.36",
"sameAs": [
"https://app.dimensions.ai/discover/publication?and_facet_researcher=ur.014767761117.36"
],
"type": "Person"
}
],
"citation": [
{
"id": "sg:pub.10.1038/nature09027",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1004439184",
"https://doi.org/10.1038/nature09027"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/1755-8794-4-77",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1044919098",
"https://doi.org/10.1186/1755-8794-4-77"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-007-9632-6",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1039484580",
"https://doi.org/10.1007/s10549-007-9632-6"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10911-005-2538-1",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1032014057",
"https://doi.org/10.1007/s10911-005-2538-1"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1097/01.lab.0000017371.72714.c5",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1047386948",
"https://doi.org/10.1097/01.lab.0000017371.72714.c5"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr1029",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1022340313",
"https://doi.org/10.1186/bcr1029"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/978-3-540-37696-5_12",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1028336106",
"https://doi.org/10.1007/978-3-540-37696-5_12"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1023/a:1015714305420",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1009081275",
"https://doi.org/10.1023/a:1015714305420"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/sj.bjc.6604174",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1038970304",
"https://doi.org/10.1038/sj.bjc.6604174"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1186/bcr2245",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1041415875",
"https://doi.org/10.1186/bcr2245"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1038/nature10166",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1000736346",
"https://doi.org/10.1038/nature10166"
],
"type": "CreativeWork"
},
{
"id": "sg:pub.10.1007/s10549-010-0983-z",
"sameAs": [
"https://app.dimensions.ai/details/publication/pub.1035116719",
"https://doi.org/10.1007/s10549-010-0983-z"
],
"type": "CreativeWork"
}
],
"datePublished": "2013-09-04",
"datePublishedReg": "2013-09-04",
"description": "IntroductionWe hypothesized that cells present in normal tissue that bear cancer stem cell markers may represent a cancer cell of origin or a microenvironment primed for tumor development, and that their presence may correlate with the clinically defined subtypes of breast cancer that show increased tumorigenicity and stem cell features.MethodsNormal tissues sampled at least 5 cm from primary tumors (normal adjacent tissue) were obtained from 61 chemotherapy-naive patients with breast cancer treated with mastectomy. Samples were stained simultaneously with immunofluorescence for CD44/CD49f/CD133/2 stem cell markers. We assessed the association between CD44+CD49f+CD133/2+ staining in normal adjacent tissue and breast cancer receptor subtype (defined by the expression of the estrogen (ER), progesterone (PR), or human epidermal growth factor-2 (Her2) receptors). We also examined the correlation between CD44+CD49f+CD133/2+ immunofluorescence and each of two previously published gene signatures, one derived from stem-cell enriched tissue and one from BRCA mutated tissue expected to have defective DNA repair.ResultsPatients with triple negative breast cancer (ER\u2013/PR\u2013/HER2\u2013) expressed CD44+CD49f+CD133/2+ in 9 of 9 normal adjacent tissue samples compared with 7 of 52 ER+ and/or Her2+ tumors (P < 0.001). Further, expression of CD44+CD49f+CD133/2+ by normal adjacent tissue correlated positively with a stem cell-derived tumorigenic signature (P <0.001) and inversely with a defective DNA-repair signature (P <0.001).ConclusionNormal cells bearing cancer stem cell markers are associated with the triple negative receptor subtype of breast cancer. This study suggests stem cell staining and gene expression signatures from normal breast tissues represent novel tissue-based risk biomarkers for triple negative breast cancer. Validation of these results in additional studies of normal tissue from cancer-free women could lay the foundation for future targeted triple negative breast cancer prevention strategies.",
"genre": "article",
"id": "sg:pub.10.1186/bcr3471",
"isAccessibleForFree": true,
"isFundedItemOf": [
{
"id": "sg:grant.2622457",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.100075899",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2699089",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2438826",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2440133",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2480259",
"type": "MonetaryGrant"
},
{
"id": "sg:grant.2480267",
"type": "MonetaryGrant"
}
],
"isPartOf": [
{
"id": "sg:journal.1022375",
"issn": [
"1465-5411",
"1465-542X"
],
"name": "Breast Cancer Research",
"publisher": "Springer Nature",
"type": "Periodical"
},
{
"issueNumber": "5",
"type": "PublicationIssue"
},
{
"type": "PublicationVolume",
"volumeNumber": "15"
}
],
"keywords": [
"cancer stem cell markers",
"negative breast cancer",
"triple-negative breast cancer",
"stem cell markers",
"breast cancer",
"normal adjacent tissues",
"cell markers",
"normal tissues",
"receptor subtypes",
"breast cancer receptor subtypes",
"breast cancer prevention strategies",
"adjacent tissues",
"chemotherapy-naive patients",
"cancer prevention strategies",
"cancer-free women",
"normal breast tissue",
"adjacent tissue samples",
"normal adjacent tissue samples",
"DNA repair signature",
"gene expression signatures",
"stem cell features",
"primary tumor",
"risk biomarkers",
"prevention strategies",
"cancer",
"gene signature",
"DNA repair deficiency",
"breast tissue",
"tumor development",
"Additional studies",
"repair deficiency",
"cancer cells",
"defective DNA repair",
"tissue samples",
"subtypes",
"expression signatures",
"cell features",
"tissue",
"tumors",
"markers",
"cell staining",
"immunofluorescence",
"staining",
"enriched tissues",
"cells",
"ResultsPatients",
"mastectomy",
"patients",
"HER2",
"IntroductionWe",
"BRCA",
"biomarkers",
"DNA repair",
"women",
"tumorigenicity",
"association",
"study",
"repair",
"microenvironment",
"deficiency",
"expression",
"samples",
"correlation",
"presence",
"signatures",
"development",
"strategies",
"validation",
"origin",
"features",
"results",
"future",
"foundation"
],
"name": "Cancer stem cell markers are enriched in normal tissue adjacent to triple negative breast cancer and inversely correlated with DNA repair deficiency",
"pagination": "r77",
"productId": [
{
"name": "dimensions_id",
"type": "PropertyValue",
"value": [
"pub.1026013878"
]
},
{
"name": "doi",
"type": "PropertyValue",
"value": [
"10.1186/bcr3471"
]
},
{
"name": "pubmed_id",
"type": "PropertyValue",
"value": [
"24008095"
]
}
],
"sameAs": [
"https://doi.org/10.1186/bcr3471",
"https://app.dimensions.ai/details/publication/pub.1026013878"
],
"sdDataset": "articles",
"sdDatePublished": "2022-08-04T17:01",
"sdLicense": "https://scigraph.springernature.com/explorer/license/",
"sdPublisher": {
"name": "Springer Nature - SN SciGraph project",
"type": "Organization"
},
"sdSource": "s3://com-springernature-scigraph/baseset/20220804/entities/gbq_results/article/article_609.jsonl",
"type": "ScholarlyArticle",
"url": "https://doi.org/10.1186/bcr3471"
}
]
Download the RDF metadata as: json-ld nt turtle xml License info
JSON-LD is a popular format for linked data which is fully compatible with JSON.
curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/pub.10.1186/bcr3471'
N-Triples is a line-based linked data format ideal for batch operations.
curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/pub.10.1186/bcr3471'
Turtle is a human-readable linked data format.
curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/pub.10.1186/bcr3471'
RDF/XML is a standard XML format for linked data.
curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/pub.10.1186/bcr3471'
This table displays all metadata directly associated to this object as RDF triples.
362 TRIPLES
21 PREDICATES
127 URIs
107 LITERALS
24 BLANK NODES